Absolute Return Capital’s Eli Lilly LLY Stock Holding History

Absolute Return Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-256,256	Closed	-$21.4M	–	560
2015 Q2	$21.4M	Sell	256,256 -62,775	-20%	-$4.78M	0.85%	18
2015 Q1	$23.2M	Sell	319,031 -268	-0.1%	-$19.1K	0.61%	45
2014 Q4	$22M	Sell	319,299 -213,434	-40%	-$14.4M	0.45%	65
2014 Q3	$34.5M	Sell	532,733 -197,303	-27%	-$12.5M	0.48%	57
2014 Q2	$45.4M	Buy	730,036 +74,764	+11%	+$4.46M	0.53%	37
2014 Q1	$38.6M	Sell	655,272 -409,640	-38%	-$22.9M	0.56%	33
2013 Q4	$54.3M	Sell	1,064,912 -191,090	-15%	-$9.57M	0.6%	35
2013 Q3	$63.2M	Buy	1,256,002 +643,901	+105%	+$33.7M	0.88%	8
2013 Q2	$30.1M	Buy	+612,101	New	+$33.3M	0.39%	71

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Absolute Return Capital's LLY Position: Q3 2015 in Review

Absolute Return Capital sold out of Eli Lilly (LLY) in Q3 2015, closing a stake of 256,256 shares — an estimated $21.4M sold.

Absolute Return Capital first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $63.2M in Q3 2013. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

Absolute Return Capital reported no remaining Eli Lilly position as of Q3 2015 after selling out during the quarter.
Absolute Return Capital sold 256,256 Eli Lilly shares in Q3 2015, an estimated $21.4M.
Absolute Return Capital first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
Absolute Return Capital's Eli Lilly position peaked at $63.2M in Q3 2013.
1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.